Letter--The Authors Respond.
Journal
Journal of managed care & specialty pharmacy
ISSN: 2376-1032
Titre abrégé: J Manag Care Spec Pharm
Pays: United States
ID NLM: 101644425
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
30
1
2020
Statut:
ppublish
Résumé
No additional funding was received for the writing of this letter. The published study referred to in this letter was funded by Janssen Scientific Affairs, which employs Maiese and funded Cornerstone Research Group, a health economic consulting group, to conduct the study. Grima is a founding partner of Cornerstone Research Group, which employs Hollmann, Goyert, and Moldaver.
Identifiants
pubmed: 31456500
doi: 10.18553/jmcp.2019.25.9.1028
pmc: PMC10398007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1028-1030Références
J Manag Care Spec Pharm. 2019 Apr;25(4):449-459
pubmed: 30917078
J Clin Oncol. 2016 Nov 10;34(32):3921-3930
pubmed: 27601539
J Med Econ. 2016 Nov;19(11):1061-1074
pubmed: 27224006
Lancet Oncol. 2017 Oct;18(10):1327-1337
pubmed: 28843768
Haematologica. 2018 Dec;103(12):2079-2087
pubmed: 30237264
N Engl J Med. 2015 Jan 8;372(2):142-52
pubmed: 25482145
Haematologica. 2018 Dec;103(12):2088-2096
pubmed: 30237262